Filing Flows › DarioHealth (DRIO) › Q1 2026
DarioHealth (DRIO) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 13, 2026
DarioHealth (DRIO) reported revenue of $5.6M for the first quarter 2026 (Q1 2026), -17% from a year earlier and +7% from the quarter before. Operating margin was -130.9%, net loss $8.2M (147.7% of revenue).
DarioHealth, Q1 2026: revenue $5.6M (-17% year over year), operating margin -130.9%, net loss $8.2M, operating cash flow −$6.0M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.6M | +7% | -17% |
| Operating profit | −$7.3M | — | — |
| Net earnings | −$8.2M | — | — |
| Operating cash flow | −$6.0M | — | — |
What changed
Revenue was $5.6M in Q1 2026, down 17% year over year and up 7% from the previous quarter. Services was the largest line at 51% of revenue. Services lost $2.0M year over year (down 42%), 175% of the total change.
Gross margin was 57.3%, down 0.2 points from Q1 2025. Operating costs exceeded revenue by $7.3M, an operating margin of -130.9%. Operating expenses fell 21% while revenue fell 17%. The quarter ended with a net loss of $8.2M, narrower than the previous quarter's $9.0M loss.
Operating cash flow was −$6.0M. Non-cash charges added back $524K of depreciation and amortization and $1.4M of share-based compensation. Capital expenditures of $31K exceeded it, leaving free cash flow of −$6.1M.
Questions
What was DarioHealth's revenue in the first quarter 2026?
DarioHealth (DRIO) reported revenue of $5.6M for the first quarter 2026 (Q1 2026), -17% from a year earlier and +7% from the quarter before.
Was DarioHealth profitable in the first quarter 2026?
Operating loss was $7.3M (-130.9% of revenue) and net loss $8.2M.
Source: DarioHealth 10-Q on SEC EDGAR.